Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases
- 30 August 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (18), 6629-6639
- https://doi.org/10.1021/jm100540x
Abstract
The discovery and characterization of 7k (BMS-582949), a highly selective p38α MAP kinase inhibitor that is currently in phase II clinical trials for the treatment of rheumatoid arthritis, is described. A key to the discovery was the rational substitution of N-cyclopropyl for N-methoxy in 1a, a previously reported clinical candidate p38α inhibitor. Unlike alkyl and other cycloalkyls, the sp2 character of the cyclopropyl group can confer improved H-bonding characteristics to the directly substituted amide NH. Inhibitor 7k is slightly less active than 1a in the p38α enzymatic assay but displays a superior pharmacokinetic profile and, as such, was more effective in both the acute murine model of inflammation and pseudoestablished rat AA model. The binding mode of 7k with p38α was confirmed by X-ray crystallographic analysis.Keywords
This publication has 37 references indexed in Scilit:
- Discovery and Evaluation of 7-Alkyl-1,5-bis-aryl-pyrazolopyridinones as Highly Potent, Selective, and Orally Efficacious Inhibitors of p38α Mitogen-Activated Protein Kinase⊥⊥ Atomic coordinates and structure factors for crystal structure of compound3dwith p38α can be accessed using PDB code 3LHJ.Journal of Medicinal Chemistry, 2010
- Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinaseBioorganic & Medicinal Chemistry Letters, 2009
- Discovery of Highly Selective and Potent p38 Inhibitors Based on a Phthalazine ScaffoldJournal of Medicinal Chemistry, 2008
- p38 MAP kinase inhibitors. Part 5: Discovery of an orally bio-available and highly efficacious compound based on the 7-amino-naphthyridone scaffoldBioorganic & Medicinal Chemistry Letters, 2006
- The Biology of p38 Kinase: A Central Role in InflammationCurrent Topics in Medicinal Chemistry, 2005
- The p38 MAP kinase pathway as a therapeutic target in inflammatory diseaseCurrent Opinion in Pharmacology, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- 1 p38 MAP Kinase: Molecular Target for the Inhibition of Pro-inflammatory CytokinesProgress in Medicinal Chemistry, 2001
- p38 MAPK signalling cascades in inflammatory diseaseMolecular Medicine Today, 1999
- A protein kinase involved in the regulation of inflammatory cytokine biosynthesisNature, 1994